Sophie V. Vandebroek - 11 May 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Sophie V. Vandebroek
Issuer symbol
IDXX
Transactions as of
11 May 2022
Transactions value $
$0
Form type
4
Filing time
13 May 2022, 17:59:23 UTC
Previous filing
14 May 2021
Next filing
05 May 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +224 +34.57% $0.00 872 11 May 2022 Direct
holding IDXX Common Stock 8.67K 11 May 2022 by Sophie V. Vandebroek Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award +945 945 11 May 2022 Common Stock 945 $333.90 Direct F1, F4
transaction IDXX Restricted Stock Unit Award +344 +153.57% 568 11 May 2022 Common Stock 344 Direct F2, F4
transaction IDXX Restricted Stock Unit Options Exercise -224 -39.44% 344 11 May 2022 Common Stock 224 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier.
F2 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest in in one installment on the one year anniversary of the date of grant or on the date of the 2023 annual meeting of shareholders, whichever event is earlier.
F3 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in one installment on the one year anniversary of the date of grant or on the date of the 2022 annual meeting of shareholders, whichever event was earlier.
F4 Not applicable.